Study Identifies Gene for Ovarian Cancer

NOVEMBER 01, 2005

An excess of the Rsf-1 gene may play an important role in the development of ovarian cancer, based on an analysis of tissue from 7 ovarian cancer samples. Using a digital karyotyping technique to identify "subchromosomal alterations," the researchers observed an overproduction of the Rsf-1 gene located on chromosome 11 in 13.2% of the most aggressive forms of ovarian cancer. These results were not seen in any of the low-grade ovarian cancers.

Because this was the first study to identify this genetic alteration, the new finding may lead to the development of a drug to block the activity of Rsf-1 and therefore stop the cancerous cell growth, concluded senior researcher Tian-Li Wang, PhD, in the Proceedings of the National Academy of Sciences (September 27, 2005).




SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.